Phase I Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors

NCT02133157 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hutchison Medipharma Limited